IL13RA2 and hepatocellular carcinoma: In hepatocellular carcinoma, elevated IL13RA2 correlated with improved patient survival, while silencing IL13RA2 had pro-proliferative, pro-survival effects analogous to those reported here, albeit via ERK activation [24].